Novel steroids of the oestrane series substituted in 7-position

Abstract

The invention relates to novel 7-substituted-steroids of the oestrane series of the general formula: ##SPC1## In which Ring A including carbon atom 6 is ##SPC2## R.sub.1 = an alkyl group with 1-4 C-atoms, R.sub.2 = oxygen or (.alpha.Y)(.beta.Z), in which Y = hydrogen or a saturated or unsaturated alkyl group with 1-4 C-atoms and Z = a free, esterified or etherified hydroxyl group, R.sub.3 = hydrogen or a free or esterified hydroxyl group, R.sub.4 = an alkylene- or alkylidene group with 1-3 C-atoms, R.sub.5 = hydrogen or a free, esterified or etherified hydroxyl group, R.sub.6 = H.sub.2, O, H(OH), H(Oalkyl) or H(Oacyl), X = H, an acyl group or an alkyl-, aralkyl-, cycloalkyl- or heterocyclic alkyl group, and A double bond is present starting from carbon atom 5, and to processes for their preparation. These novel steroids possess anabolic, androgenic, oestrogenic, progestative, ovulation-inhibiting and gonad-inhibiting properties.

Dependencies are inferred from the claim text.